报告人：Prof. Rachela Popovtzer, Bar-Ilan University
报告题目：Nanotheranostics for Personalized Medicine
报告时间：2：00 PM, Dec 25th (Monday)
报告地点：909-B
Abstract
The development of biocompatible nanoparticles for molecular imaging and targeted therapy is an area of considerable current interest across a number of disciplines. Nanoparticles are expected to play a major role in the future of medical theranostics due to their many advantages over the conventional contrast agents and over small-molecular-weight drugs, such as prolonged blood circulation time, controlled biological clearance pathways and specific molecular targeting capabilities. In this presentation, we will share our recent work with gold nanoparticles including early diagnosis of diseases, targeted drug delivery with fewer side effects, and novel therapeutic approaches. In addition, the use of gold nanoparticles for in vivo cell tracking and for stratified medicine will be presented.
Biography
Rachela Popovtzer is an Associate Professor, Head of the Bioengineering Track and Head of the Laboratory of Nanomedicine in the Faculty of Engineering at Bar Ilan University, which she joined in 2008. She is a member of the Bar-Ilan Institute of Nanotechnology and Advanced Materials (BINA). She was a Visiting Professor at Memorial Sloan Kettering Cancer Center during 2016. Prof. Popovtzer received her M.Sc. and PhD in Electrical Engineering from Tel Aviv University, and her B.Sc. in Physics from BIU. She was a postdoctoral fellow in the University of Michigan with Prof. Raoul Kopelman. Prof. Popovtzer is a winner of numerous international grants and awards, such as the Intel Prize, NIH grant, the EU horizon 2020 grant and the Atol Charitable Trust Fellow in Nano Medicine.
Contact: Prof. Zhuang Liu
责任编辑：杨娟